Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1414 studies found for:    "Multiple Sclerosis"
Show Display Options
RSS Create an RSS feed from your search for:
"Multiple Sclerosis"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Terminated Memantine Therapy for Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Memantine;   Drug: Placebo
2 Completed Constraint-Induced (CI) Movement Therapy for Progressive Multiple Sclerosis (MS)
Condition: Multiple Sclerosis
Intervention: Behavioral: Constraint-Induced Movement Therapy
3 Completed Sodium Intake in Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention:
4 Completed Testosterone Treatment for Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: Androgel 100mg gel
5 Recruiting Phase 2 Study of Ublituximab in Patients With Relapsing Forms of Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Biological: Ublituximab;   Drug: Placebo
6 Withdrawn Head Circumference Growth in Children Who Develop Multiple Sclerosis Later in Life
Condition: Multiple Sclerosis
Intervention:
7 Completed
Has Results
Duloxetine for Multiple Sclerosis Pain
Condition: Multiple Sclerosis
Interventions: Drug: Duloxetine Hydrochloride (HCI);   Drug: Placebo
8 Completed Efficacy, Safety, and Tolerability of Nerispirdine in Patients With Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Nerispirdine;   Drug: placebo
9 Completed Low Fat Diet and Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Other: Low fat study diet
10 Unknown  Characteristic Study on Chinese Patients With Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: atorvastatin;   Drug: β-interferon;   Drug: EPO
11 Recruiting Oral Ponesimod Versus Teriflunomide In Relapsing MUltiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: ponesimod;   Drug: teriflunomide
12 Completed
Has Results
An Efficacy Study of Teriflunomide in Participants With Relapsing Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Placebo;   Drug: Teriflunomide
13 Completed
Has Results
Rebif New Formulation (RNF) in Relapsing Forms of Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Biological: Interferon-beta-1a FBS-free/HSA-free
14 Completed
Has Results
12-week Study to Evaluate RebiSmart™ Suitability for Self Injection in Relapsing Multiple Sclerosis.
Condition: Multiple Sclerosis
Intervention: Drug: Rebif® New Formulation (RNF) using RebiSmartTM
15 Terminated Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks
Condition: Multiple Sclerosis
Interventions: Drug: megadose oral methylprednisolone;   Drug: IV methylprednisolone
16 Not yet recruiting Use of an Electronic Diary by People With Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Device: e-diary
17 Completed Integrative Group-based Cognitive Rehabilitation Efficacy in Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Other: cognitive remediation program: REHACOP
18 Completed Evaluation of Autologous Mesenchymal Stem Cell Transplantation (Effects and Side Effects) in Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Biological: intravenous injection of mesenchymal stem cells;   Biological: injection of cell free media
19 Not yet recruiting A Study to Evaluate the Safety of Long Term Treatment With Teriflunomide 14 mg Once Daily in Patients With a First Clinical Episode Suggestive of Multiple Sclerosis in a Long-term Extension Period
Condition: Multiple Sclerosis
Intervention: Drug: Teriflunomide
20 Suspended [11C]-PBR28 Positron Emission Tomography Study to Evaluate the Effect of ABT 555 in Subjects With Relapsing Forms of Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: ABT-555

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.